Michael Bergman,Muhammad Abdul-Ghani,Juliana Chan et al.
Michael Bergman et al.
Frank J Snoek
Frank J Snoek
Depression symptoms, wellbeing, health-related quality of life, and diabetes-related distress in novel subtypes of recent-onset diabetes in Germany: a 5-year observational follow-up study [0.03%]
德国近期发病糖尿病新型亚型的抑郁症状、健康和生活质量以及糖尿病相关的精神压力：一项为期五年的观察随访研究
Jana Sommer,Sandra Olivia Borgmann,Veronika Gontscharuk et al.
Jana Sommer et al.
Background: The subjective experiences of individuals living with diabetes is commonly assessed with patient-reported outcomes (PROs; eg, depression symptoms, wellbeing, health-related quality of life [HRQOL], and diabete...
Observational Study
The lancet. Diabetes & endocrinology. 2024 Dec;12(12):890-903. DOI:10.1016/S2213-8587(24)00234-1 2024
Soon H Song,Brian M Frier
Soon H Song
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92) [0.03%]
年轻发病与老年发病2型糖尿病患者的对比：为期长达30年的前瞻性研究（UKPDS）第92项分析
Beryl Lin,Ruth L Coleman,Fiona Bragg et al.
Beryl Lin et al.
Background: Younger-onset type 2 diabetes is associated with accelerated complications. We assessed whether complications and mortality rates differed for younger age compared with older age at diagnosis over 30 years of ...
Lomitapide for the treatment of homozygous familial hypercholesterolaemia in children [0.03%]
用于儿童纯合子家族性高胆固醇血症治疗的洛米肽 препарат ломитапид для лечения гетерозиготной семейной гиперхолестеринемии у детей
Liam R Brunham,Robert A Hegele
Liam R Brunham
Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study [0.03%]
用于纯合子家族性高胆固醇血症儿童患者的乐美他派治疗：III期开放标签多中心研究的效用阶段结果摘要(APH-19)
Luis Masana,Alberto Zambon,Claus Peter Schmitt et al.
Luis Masana et al.
Background: Homozygous familial hypercholesterolaemia (HoFH) is a rare inherited disorder characterised by extremely high concentrations of LDL cholesterol, leading to early-onset atherosclerosis. Lomitapide is an orally ...
Declaration of Lisbon [0.03%]
《里斯本宣言》
Catarina Limbert,Jamie Wood,Sabine Hofer et al.
Catarina Limbert et al.
Is it time to revisit the recommendations for initiation of menopausal hormone therapy? [0.03%]
重新审视开始使用绝经过渡期激素治疗的建议时机了吗？
Sasha Taylor,Susan R Davis
Sasha Taylor
Findings from the Women's Health Initiative studies led to menopausal hormone therapy (MHT) guidelines generally recommending the initiation of MHT be limited to women within 10 years of their menopause or before the age of 60 years. This r...
Nick Oliver,Monika Reddy,Lala Leelarathna
Nick Oliver
The promotion of continuous glucose monitoring (CGM) to standard of care for type 1 diabetes and insulin-treated type 2 diabetes reflects a robust and wide evidence base for the technology's effectiveness supported by real-world efficacy da...